CSL breaks ground on $1.5B expansion of Illinois plasma therapy manufacturing facility

CSL broke ground on a $1.5 billion expansion of its plasma-derived therapies manufacturing facility in Kankakee, Illinois, on March 9, 2026. The expansion will create at least 300 new jobs and is expected to be operational by 2031.

“This site expansion marks an important step in our commitment to serving patients with rare and serious diseases.”newsroom.csl.com

• 1 source
• newsroom.csl.comCSL announces expansion of Illinois plasma therapy manufacturing facilityMar 9, 2026

Summarized from public sources; check the original articles before acting on it.